This company has been marked as potentially delisted and may not be actively trading. Nuwellis (CHFS) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock CHFS vs. QTI, NRXS, VRAYQ, VIVE, ELMD, IPA, SCLX, LUCD, FATE, and ACOGShould you be buying Nuwellis stock or one of its competitors? The main competitors of Nuwellis include QT Imaging (QTI), NeurAxis (NRXS), ViewRay (VRAYQ), Viveve Medical (VIVE), Electromed (ELMD), ImmunoPrecise Antibodies (IPA), Scilex (SCLX), Lucid Diagnostics (LUCD), Fate Therapeutics (FATE), and Alpha Cognition (ACOG). These companies are all part of the "medical" sector. Nuwellis vs. Its Competitors QT Imaging NeurAxis ViewRay Viveve Medical Electromed ImmunoPrecise Antibodies Scilex Lucid Diagnostics Fate Therapeutics Alpha Cognition Nuwellis (NASDAQ:CHFS) and QT Imaging (NASDAQ:QTI) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, institutional ownership, media sentiment, profitability, analyst recommendations, risk, valuation and dividends. Which has better valuation and earnings, CHFS or QTI? QT Imaging has lower revenue, but higher earnings than Nuwellis. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNuwellis$5.51M5.40-$18.11M-$279.28-0.02QT Imaging$4.00M16.90-$4.03MN/AN/A Which has more volatility & risk, CHFS or QTI? Nuwellis has a beta of 1.55, suggesting that its stock price is 55% more volatile than the S&P 500. Comparatively, QT Imaging has a beta of -0.2, suggesting that its stock price is 120% less volatile than the S&P 500. Is CHFS or QTI more profitable? QT Imaging has a net margin of 0.00% compared to Nuwellis' net margin of -254.26%. QT Imaging's return on equity of 0.00% beat Nuwellis' return on equity.Company Net Margins Return on Equity Return on Assets Nuwellis-254.26% -173.61% -131.01% QT Imaging N/A N/A -65.94% Do institutionals & insiders believe in CHFS or QTI? 65.1% of Nuwellis shares are owned by institutional investors. Comparatively, 24.2% of QT Imaging shares are owned by institutional investors. 0.6% of Nuwellis shares are owned by insiders. Comparatively, 75.4% of QT Imaging shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Does the media prefer CHFS or QTI? In the previous week, QT Imaging had 3 more articles in the media than Nuwellis. MarketBeat recorded 3 mentions for QT Imaging and 0 mentions for Nuwellis. QT Imaging's average media sentiment score of 1.17 beat Nuwellis' score of 0.00 indicating that QT Imaging is being referred to more favorably in the news media. Company Overall Sentiment Nuwellis Neutral QT Imaging Positive SummaryQT Imaging beats Nuwellis on 8 of the 11 factors compared between the two stocks. Get Nuwellis News Delivered to You Automatically Sign up to receive the latest news and ratings for CHFS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CHFS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CHFS vs. The Competition Export to ExcelMetricNuwellisElectromedical Equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$29.73M$40.71M$5.76B$9.85BDividend YieldN/AN/A6.66%4.49%P/E Ratio-0.103.6482.4826.51Price / Sales5.40209.59500.41161.56Price / CashN/A41.3625.7028.92Price / Book0.392.6610.816.51Net Income-$18.11M-$2.66M$3.28B$266.22M Nuwellis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CHFSNuwellisN/A$4.93-2.5%N/A+255.6%$29.73M$5.51M-0.1066Gap DownQTIQT ImagingN/A$2.33+9.4%N/A+261.1%$63.22M$4.00M0.00N/APositive NewsGap UpNRXSNeurAxis3.4959 of 5 stars$2.45-3.5%$7.00+185.7%-18.8%$24.16M$3.22M-1.3319Short Interest ↓Gap DownVRAYQViewRayN/AN/AN/AN/A$18K$102.21M0.00300VIVEViveve MedicalN/A$0.00flatN/AN/A$1K$6.83M0.0070ELMDElectromed3.0548 of 5 stars$20.66+2.3%$33.50+62.1%+39.4%$173.26M$61.44M27.55160IPAImmunoPrecise Antibodies2.7205 of 5 stars$2.75-0.4%$4.00+45.5%+195.7%$127.39M$17.59M-4.0480Short Interest ↓Gap UpSCLXScilex2.6342 of 5 stars$18.02-1.5%$455.00+2,425.0%-51.0%$127.22M$44.24M-0.6280News CoveragePositive NewsLUCDLucid Diagnostics2.7561 of 5 stars$1.18+1.7%$3.55+200.8%+53.1%$125.83M$4.35M-0.9970FATEFate Therapeutics3.8214 of 5 stars$1.11+1.8%$3.30+197.3%-71.0%$125.71M$13.63M-0.77550ACOGAlpha Cognition2.5087 of 5 stars$7.93+2.7%$20.00+152.2%N/A$124.84MN/A-4.96N/APositive News Related Companies and Tools Related Companies QTI Alternatives NRXS Alternatives VRAYQ Alternatives VIVE Alternatives ELMD Alternatives IPA Alternatives SCLX Alternatives LUCD Alternatives FATE Alternatives ACOG Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CHFS) was last updated on 9/4/2025 by MarketBeat.com Staff From Our Partners“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWashington prepares for warWhile the headlines obsess over overseas conflicts, Washington has been quietly preparing for something much b...Porter & Company | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredFree: The Crypto Summit That Could Change Your Life27 industry leaders share urgent market intel (free access)... For a very limited time, you can claim your ...Crypto 101 Media | SponsoredThis Massive Market is Ripe for Disruption by this NasdaqFanatics Hit $31B. This Nasdaq Company Is Building the Next Wave Fanatics built a merch empire by owning th...i2i Marketing Group, LLC | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nuwellis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nuwellis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CHFS Stock Alerts